Le Lézard
Classified in: Health, Covid-19 virus
Subjects: SVY, CPG

COVID-19 Pandemic - The government presents its daily update


QUÉBEC CITY, June 21, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:

Vaccination

Summary Data Evolution Table1

Date

Confirmed
cases

Deaths2

Hospitalizations

Hospitalizations
in intensive
care

Tests
performed

Administered
doses of
vaccine3

June 14

105

1

209 (-5)

50 (-4)

24,849

90,899

June 15

153

1

192 (-17)

45 (-5)

24,686

86,623

June 16

161

1

178 (-14)

41 (-4)

22,677

97,781

June 17

127

2

175 (-3)

39 (-2)

19,619

101,905

June 18

160

0

178 (+3)

39

17,300

91,057

June 19

103

0

170 (-8)

39

16,307

71,745

June 20

90

0

168 (-2)

39

NA

57,004

1 Note that the majority of data are presented according to the day they were entered. They are extracted at 4 p.m. at the date shown and cover the preceding 24 hours. However, the availability of the data on samples involves an additional delay of 24 hours and these correspond to the number of samples taken on the date shown.

2 It should also be noted that the data prior to those of the last 24 hours presented in the column Deaths have been adjusted according to the actual dates of death. This explains the variation of some data compared to those presented in previous press releases. The daily death toll is influenced by the time required for the physician to report the death, the time required to complete the investigation to confirm that the death was attributable to COVID-19, and the entry into the system.

3 Note that the number of doses administered may be subject to daily readjustment for the previous days, due to catching up due to a delay in data entry.

A reminder concerning public health instructions:

To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.

Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.

Related links:

SOURCE Ministère de la Santé et des Services sociaux


These press releases may also interest you

at 01:20
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

18 avr 2024
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: